This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.

BILL ANALYSIS

 

 

Senate Research Center                                                                                                     H.B. 2330

81R11442 JSC-D                                                                                            By: Guillen (Zaffirini)

                                                                                                                  Health & Human Services

                                                                                                                                              5/2/2009

                                                                                                                                           Engrossed

 

 

AUTHOR'S / SPONSOR'S STATEMENT OF INTENT

 

Chronic kidney disease (CKD) is recognized as a major public health threat worldwide.  Texas has the second-highest prevalence of CKD in the nation.  CKD, if not maintained, results in end-stage renal disease which requires the use of renal replacement therapy.  In Texas, there are 42,000 residents receiving lifesaving renal replacement therapy which can cost up to $70,000 a year.  Early detection and management of CKD can delay disease progression and decrease complications and comorbidities, but CKD remains underdiagnosed.  The National Kidney Foundation has concluded that calculating a person's estimated glomerular filtration rate (GFR) is the best method for estimating kidney function and determining the current stage of kidney disease.  GFR helps determine which patients with chronic kidney disease (CKD) will develop end-stage renal disease and helps physicians identify patients at high risk of serious kidney trouble so that they may intervene at an early stage.

 

This bill would require a laboratory that performs a serum creatinine test on a sample from a person 18 years of age or older to also calculate and include in the reported results the person's estimated GFR.  

 

H.B. 2330 relates to laboratory tests measuring kidney function.

 

RULEMAKING AUTHORITY

 

This bill does not expressly grant any additional rulemaking authority to a state officer, institution, or agency.

 

SECTION BY SECTION ANALYSIS

 

SECTION 1.  Amends Section 42.002, Health and Safety Code, by adding Subdivisions (3) and (4), to define "serum creatinine test" and "estimated glomerular filtration rate."

 

SECTION 2.  Amends Chapter 42, Health and Safety Code, by adding Section 42.0047, as follows:

 

Sec. 42.0047.  ESTIMATED GLOMERULAR FILTRATION RATE REPORTING.  Requires a laboratory that performs a serum creatinine test on a sample from a person 18 years of age or older to also calculate and include in the reported results the person's estimated glomerular filtration rate.

 

SECTION 3.  Makes application of this Act prospective.

 

SECTION 4.  Effective date: September 1, 2009.